Comments from the American Academy of Pain Medicine
The American Academy of Pain Medicine thanks the Agency for the opportunity to comment on The Evidence-based Practice Center Program at the Agency for Healthcare Research and Quality key questions for the systematic review on Management of Primary Headaches in Pregnancy.
The questions listed here are very well thought out, however we do want to make some comments that may help the direction of the review.
- What are the harms or comparative harms of treatments for migraine or other headaches during pregnancy?
- What are the harms comparative harms of interventions to prevent migraine during pregnancy?
- What is the effectiveness or comparative effectiveness of treatment for migraine for women during pregnancy?
- What is the effectiveness or comparative effectiveness of interventions to prevent migraines for women during pregnancy?
In looking at the groups and questions that are fleshed out in the document, it appears that you are clumping pregnant, post-partum, and nursing migraines into the same cohort. This may not be factually correct. In general, women’s headaches present very differently during these time periods and interventions may also be different, thus we would encourage separating these groups.
Thank you for this opportunity and please feel free to contact us if we can be of any further assistance.
The American Academy of Pain Medicine is the premier medical association for pain clinicians and their treatment teams with some 2,000 members. Now in its 36th year of service, the Academy’s mission is to advance and promote the full spectrum of multidisciplinary pain care, education, advocacy, and research to improve function and quality of life for people in pain. Information is available on the Academy’s website at painmed.org.
Approved by the AAPM Executive Committee on April 11, 2019